Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03157349 · ClinicalTrials.gov registry record · NA

Effect of Biofreeze® Versus Placebo on Acute Neck Pain, Disability, and Range of Motion

A NA study, sponsored by Sport and Spine Rehab Clinical Research Foundation.

Completed
Registry status
NA
Development phase
59
Enrollment target

NCT03157349: Completed NA study, sponsored by Sport and Spine Rehab Clinical Research Foundation.

NCT03157349 is a NA study that has completed, run by Sport and Spine Rehab Clinical Research Foundation. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03157349, a NA study, has completed, sponsored by Sport and Spine Rehab Clinical Research Foundation.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target

Study Summary

The purpose of this study to compare the effect of Biofreeze® versus a Placebo on neck pain, disability, fear avoidance, and range of motion prior to and following cervical manipulation over the course of one week among patients with acute neck pain.

Interventions

  • OTHER Placebo
  • OTHER Biofreeze

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2017-03-01
Est. Completion 2019-02-01
Phase NA

What the finished NCT03157349 record still lists

NCT03157349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03157349 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03157349 about?

NCT03157349 is a clinical study titled "Effect of Biofreeze® Versus Placebo on Acute Neck Pain, Disability, and Range of Motion". The purpose of this study to compare the effect of Biofreeze® versus a Placebo on neck pain, disability, fear avoidance, and range of motion prior to and following cervical manipulation over the course of one week among patients with acute neck pain.

What is the current status of trial NCT03157349?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2017-03-01. Estimated completion is 2019-02-01.

What interventions are being tested in trial NCT03157349?

The interventions under investigation include: Placebo (OTHER), Biofreeze (OTHER).

Who is sponsoring clinical trial NCT03157349?

This trial is sponsored by Sport and Spine Rehab Clinical Research Foundation, which has 16 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03157349's enrollment target sits among peer trials

59 1256th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03801083 · 59 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

  • NCT04332367 · 59 participants · Phase 2

    Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

  • NCT05489575 · 59 participants · NA

    CPAP for the Treatment of Supine Hypertension

  • NCT06721689 · 59 participants · Phase 1

    PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03157349, the US trial registry maintained by the National Library of Medicine. NCT03157349 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.